Mechanism and resistance for antimycobacterial activity of a fluoroquinophenoxazine compound.
We have previously reported the inhibition of bacterial topoisomerase I activity by a fluoroquinophenoxazine compound (FP-11g) with a 6-bipiperidinyl lipophilic side chain that exhibited promising antituberculosis activity (MIC = 2.5 μM against Mycobacterium tuberculosis, SI = 9.8). Here, we found t...
Main Authors: | Pamela K Garcia, Thirunavukkarasu Annamalai, Wenjie Wang, Raven S Bell, Duc Le, Paula Martin Pancorbo, Sabah Sikandar, Ahmed Seddek, Xufen Yu, Dianqing Sun, Anne-Catrin Uhlemann, Purushottam B Tiwari, Fenfei Leng, Yuk-Ching Tse-Dinh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0207733 |
Similar Items
-
Type IA Topoisomerases as Targets for Infectious Disease Treatments
by: Ahmed Seddek, et al.
Published: (2021-01-01) -
Macrocyclic Drugs and Synthetic Methodologies toward Macrocycles
by: Xufen Yu, et al.
Published: (2013-05-01) -
Inhibition of Zn(II) binding type IA topoisomerases by organomercury compounds and Hg(II).
by: Bokun Cheng, et al.
Published: (2015-01-01) -
Antimycobacterial Activity of Salicylanilide Benzenesulfonates
by: Jiřina Stolaříková, et al.
Published: (2012-01-01) -
N-Alkoxyphenylhydroxynaphthalenecarboxamides and Their Antimycobacterial Activity
by: Tomas Gonec, et al.
Published: (2016-08-01)